Sun Pharmaceutical in focus as unit gets relief from US court

Shares of Sun Pharmaceutical Industries will be in focus. DUSA Pharmaceuticals, Inc., (DUSA), a wholly owned subsidiary of Sun Pharmaceutical Industries announced that DUSA has been granted preliminary injunctive relief by a federal district court prohibiting defendants Biofrontera Inc., Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and Biofrontera AG (together known as Biofrontera) from using DUSA's confidential and proprietary trade secret information. The announcement was made after market hours yesterday, 26 December 2018.

NTPC said that investment approval has been accorded for Bilhaur Solar PV Project of 140 MW capacity and Auraiya Solar PV Project of 20 MW capacity. The announcement was made after market hours yesterday, 26 December 2018.

Shares of Cimmco will be in focus. Titagarh Wagons, a part of the promoter group of company will be selling 15,43,090 shares (representing 5.64 percent of total equity) through Offer for Sale (OFS) route on December 27 and 28. The floor price of the offer is Rs 38 per share. The announcement was made after market hours yesterday, 26 December 2018.

Shanthi Gears' board approved the buyback of fully paid up equity shares of not exceeding 50 lakh equity shares (being 6.12% of the total paid-up equity capital of the company) at Rs 140 for an aggregate amount of up to Rs 70 crore. The announcement was made after market hours yesterday, 26 December 2018.

Powered by Capital Market - Live News